chenodeoxycholic acid has been researched along with Fetal Growth Retardation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, W; Chen, YH; Gao, L; Gao, XX; Li, L; Liu, ZB; Ma, L; Wang, H; Xu, DX | 1 |
| Bo, QL; Chen, YH; Fu, L; Hu, XG; Wang, H; Xu, DX; Yu, Z; Zhang, C; Zhang, GB; Zhou, Y | 1 |
2 other study(ies) available for chenodeoxycholic acid and Fetal Growth Retardation
| Article | Year |
|---|---|
Obeticholic Acid Protects against Gestational Cholestasis-Induced Fetal Intrauterine Growth Restriction in Mice.
Topics: Animals; Chenodeoxycholic Acid; Cholestasis, Intrahepatic; Estrogens; Ethinyl Estradiol; Female; Fetal Growth Retardation; Fetus; Lipid Peroxidation; Male; Mice; Mice, Inbred ICR; Oxidative Stress; Pregnancy; Pregnancy Complications; Signal Transduction | 2019 |
Obeticholic Acid Protects against Lipopolysaccharide-Induced Fetal Death and Intrauterine Growth Restriction through Its Anti-Inflammatory Activity.
Topics: Animals; Anti-Inflammatory Agents; Chenodeoxycholic Acid; Cytokines; Endotoxemia; Female; Fetal Death; Fetal Growth Retardation; Humans; Inflammation Mediators; Lipopolysaccharides; Male; Mice, Inbred ICR; NF-kappa B; Placenta; Pregnancy; Receptors, Cytoplasmic and Nuclear; Signal Transduction | 2016 |